创新药向上还是向下:BD交易爆发、大摩持续唱多 板块仍处调整期

每日经济新闻
Feb 24

2026年,我国创新药出海延续高景气度,最近两天先为达、前沿生物及和铂医药接连达成三笔BD(商务拓展)交易。  医药魔方NextPharma数据库显示,截至2月15日(春节假期期间暂未新增交易事件),中国创新药已发生39起license-out(对外授权)交易事件,首付款约29.53亿美元,总金额超490亿美元。  《每日经济新闻》记者注意到,这一金额已超过 2025年全年总额的1/3,中国创新药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10